肝素酶(HPSE)多克隆抗體
Polyclonal Antibody to Heparanase (HPSE)
HPA; HPR1; HPSE1; HSE1; Endo-glucoronidase;
- 編號(hào)UPAA711Hu02
 - 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
 - 來源多抗制備
 - 宿主兔
 - 效價(jià)-
 - Ig類型 IgG
 - 純化方式抗原特異性親和純化
 - 標(biāo)記物無標(biāo)記物
 - 免疫原 RPA711Hu02-肝素酶(HPSE)重組蛋白
 - 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
 - 性狀液體
 - 濃度0.5mg/mL
 - 且適物種Sus scrofa; Porcine (Pig,豬)
 - 應(yīng)用WB; IHC; ICC/IF
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
 - 規(guī)格 20μl100μl 200μl 1ml 10ml
 - 價(jià)格 ¥ 284 ¥ 664 ¥ 948 ¥ 2370 ¥ 9480
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
該抗體是針對(duì)HPSE的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別HPSE。
用法
            Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunofluorescence:5-20μg/mL;
Optimal working dilutions must be determined by end user.        
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
            抗體標(biāo)記定制服務(wù)
                    Protein-A/G純化柱
                    細(xì)胞和組織染色液
                    抗體陽性對(duì)照品
                    組織/切片定制服務(wù)
                    磷酸化抗體定制服務(wù)
                    免疫印跡(WB)實(shí)驗(yàn)服務(wù)
                    免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
                    免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
                    流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
                    免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
                    免疫熒光(IF)實(shí)驗(yàn)服務(wù)
                    緩沖液
                    DAB顯色試劑盒
                    SABC試劑盒
                    長臂生物素標(biāo)記試劑盒
                    實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
                            
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| URPA711Hu04 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA711Hu02 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UAPA711Hu04 | 肝素酶(HPSE)活性蛋白 | Cell?culture;?Activity?Assays. | 
| UAPA711Hu01 | 肝素酶(HPSE)活性蛋白 | Cell?culture;?Activity?Assays. | 
| UEPA711Hu61 | 肝素酶(HPSE)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UAPA711Hu61 | 肝素酶(HPSE)活性蛋白 | Cell?culture;?Activity?Assays. | 
| URPA711Hu01 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA711Hu03 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UCPA711Hu21 | 肝素酶(HPSE)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. | 
| UPAA711Hu04 | 肝素酶(HPSE)多克隆抗體 | IHC | 
| UPAA711Hu02 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC/IF | 
| UPAA711Hu01 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. | 
| UPAA711Hu03 | 肝素酶(HPSE)多克隆抗體 | IHC | 
| UFAA711Hu01 | 抗肝素酶(HPSE)多克隆抗體 | FCM | 
| UFAA711Hu03 | 抗肝素酶(HPSE)多克隆抗體 | FCM | 
| ULAA711Hu71 | 肝素酶(HPSE)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| UMAA711Hu23 | 肝素酶(HPSE)單克隆抗體 | ICC/IF | 
| UMAA711Hu22 | 肝素酶(HPSE)單克隆抗體 | WB; IHC; ICC; IP. | 
| UMAA711Hu21 | 肝素酶(HPSE)單克隆抗體 | WB; ICC/IF | 
| USEA711Hu | 肝素酶(HPSE)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| UHEA711Hu | 肝素酶(HPSE)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| ULMA711Hu | 肝素酶(HPSE)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| UKSA711Hu01 | 肝素酶(HPSE)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Plos one | PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model [Plosone: Source] | 
| Journal of Medical Science | Assessment of heparanase and heparin-binding growth and angiogenesis factors in the uterine cavity ? uid in women with impaired reproduction [Nowinylekarskie:Source] | 
| Int J Clin Exp Pathol | Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase [PubMed: 26191183] | 
| Tumour Biology | PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection [PubMed: 26415733] | 
| Journal of Medical Science | Assessment of heparanase and heparin-binding growth and angiogenesis factors in the uterine cavity fluid in women with impaired reproduction [article:84] | 
| Renal Failure | Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage [pubmed:28994624] | 

                    
                    
                            